Literature DB >> 7038342

Erythromycin.

M J Gribble, A W Chow.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7038342     DOI： 10.1016/s0025-7125(16)31443-2

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  13 in total

1.  The use of antimicrobial drugs in office practice.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1982-12       Impact factor: 3.275

Review 2.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

3.  Disk diffusion susceptibility testing of two macrolide antimicrobial agents: revised interpretive criteria for erythromycin and preliminary guidelines for roxithromycin (RU 965).

Authors:  R N Jones; A L Barry; P C Fuchs; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

4.  Effect of subinhibitory concentrations of macrolides on expression of flagellin in Pseudomonas aeruginosa and Proteus mirabilis.

Authors:  K Kawamura-Sato; Y Iinuma; T Hasegawa; T Horii; T Yamashino; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

5.  Erythromycin stearate as prokinetic agent in postvagotomy gastroparesis.

Authors:  H Mozwecz; D Pavel; D Pitrak; P Orellana; P K Schlesinger; T J Layden
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

6.  Current antibiotic usage II: Aminoglycosides, tetracyclines, erythromycin, vancomycin and sulphonamides.

Authors:  S M Merchant; N P Vithlani
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

7.  In vitro comparison of the activity of RU 28965, a new macrolide, with that of erythromycin against aerobic and anaerobic bacteria.

Authors:  T Barlam; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

8.  Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia.

Authors:  B J Zeluff; P Lowe; H J Koornhof; L O Gentry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-02       Impact factor: 3.267

Review 9.  Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.

Authors:  G H Cassell; K B Waites; H L Watson; D T Crouse; R Harasawa
Journal:  Clin Microbiol Rev       Date:  1993-01       Impact factor: 26.132

10.  Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.

Authors:  I O Kibwage; J Hoogmartens; E Roets; H Vanderhaeghe; L Verbist; M Dubost; C Pascal; P Petitjean; G Levol
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.